skip to contentNational Cancer Institute
National Cancer Institute U.S. National Institutes of Health www.cancer.gov
Found 431 results for your search:
Total relevant funding to Liver Cancer for this search:
$64,559,887
Fiscal Year FY 2012
Cancer Type [Liver Cancer]
Modify this Search New Search
Close

Modify Search Criteria

Some search criteria may be modified to refine your current search.

Select criteria to modify:

Add or remove search options:

Select criteria above to see additional search options

Cancel
Showing 1 - 50 of 431 results
Clipboard
Project Title Sorted ascending Project Number Funded Amount
Relevant Funding
Principal
Investigator
Institution
1
4D Robust Optimization in Intensity-Modulated Proton Therapy 1K25CA168984-01 $125,174 $62,587 Liu, Wei UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
2
A Genetic Screen for HCC Genes 5R01CA132962-03 $302,919 $302,919 LARGAESPADA, DAVID UNIVERSITY OF MINNESOTA
3
A Multidisciplinary and Translational Approach to Hepatobiliary Malignancy 5K24CA139570-03 $186,940 $186,940 Nelson, David UNIVERSITY OF FLORIDA
4
A Needle Guidance System for Hepatic Tumor Ablation That Fuses Real-Time Ultrasou 2R44CA143234-02A1 $652,814 $652,814 Razzaque, Sharif INNEROPTIC TECHNOLOGY, INC.
5
A New Method for Improved Targeting in Image-guided Abdominal Interventions 5R01CA138586-03 $359,276 $359,276 Hata, Nobuhiko BRIGHAM AND WOMEN'S HOSPITAL
6
A novel diagnostic biomarker for hepatocellular carcinoma and cholangiocarcinoma 1R43CA165314-01A1 $292,459 $292,459 Lu, Xuanyong IMCARE BIOTECH
7
A Randomized Trial of Hep B Screening and Vaccination in High Risk Vietnamese 5R01CA129763-06 $477,672 $477,672 MA, GRACE TEMPLE UNIVERSITY
8
AARP prospective study of diet and cancer ZIA CP010196-03152 $1,258,475 $62,924 Sinha, Rashmi DCEG (NCI)
9
Aberrant DNA Methylation of MicroRNA Genes in Hepatocellular Carcinoma (HCC) 5R03CA156629-02 $80,000 $80,000 Shen, Jing COLUMBIA UNIVERSITY HEALTH SCIENCES
10
Aberrantly secreted glycoproteins as markers of liver cancer 1U01CA168856-01 $293,548 $293,548 Mehta, Anand Drexel University
11
Aflatoxin B1 hepatocarcinogenesis in the mGSTA3-/- mouse 1R01CA161694-01A1 $292,725 $292,725 SELL, STEWART WADSWORTH CENTER
12
AIDS Malignancy Clinical Trials Consortium (AMC) 3U01CA121947-05S1 $450,000 $22,500 MITSUYASU, RONALD UNIVERSITY OF CALIFORNIA AT LOS ANGELES
13
AIDS Malignancy Clinical Trials Consortium (AMC) 5U01CA121947-06 $6,010,333 $300,517 MITSUYASU, RONALD UNIVERSITY OF CALIFORNIA AT LOS ANGELES
14
Alliance of Glycobiologists for Detection of Cancer 1U01CA168926-01 $387,871 $387,871 GOLDMAN, RADOSLAV GEORGETOWN UNIVERSITY
15
An Orthotopic Murine Model of HCC: Immunotolerance and Prevention 1R01CA164335-01A1 $308,449 $308,449 StaveleyO'Carroll, Kevin PENNSYLVANIA STATE UNIVERSITY
16
Analysis of a novel regulator of hepatocellular carcinoma 3R01CA138540-03S1 $56,355 $56,355 SARKAR, DEVANAND VIRGINIA COMMONWEALTH UNIVERSITY
17
Analysis of a novel regulator of hepatocellular carcinoma 5R01CA138540-03 $300,907 $300,907 SARKAR, DEVANAND VIRGINIA COMMONWEALTH UNIVERSITY
18
Analysis of LC-MS data to identify peptide and glycan biomarkers for hepatocellul 5R01CA143420-03 $278,062 $278,062 RESSOM, HABTOM GEORGETOWN UNIVERSITY
19
ANC12006-001-00000 DIET INDUCED HYPOMETHYLATION IN THE PRE-NEOPLASTIC LIVER Y01CN129006 $80,000 $80,000 UNKNOWN, UNKNOWN U.S. FOOD AND DRUG ADMINISTRATION
20
Antibody Therapy of Cancer ZIABC010891 $518,195 $362,736 Ho, Mitchell CCR (NCI)
21
Aptamer targeting of osteopontin in hepatocellular cancer 1R21CA155306-01A1 $195,098 $195,098 KUO, PAUL LOYOLA UNIVERSITY CHICAGO
22
Asian Community Cancer Health Disparities Center (ACCHDC) 3U54CA153513-03S1 $50,000 $8,000 MA, GRACE TEMPLE UNIVERSITY
23
Asian Community Cancer Health Disparities Center (ACCHDC) 5U54CA153513-03 $960,300 $153,648 MA, GRACE TEMPLE UNIVERSITY
24
Asymmetric Division and Self Renewal of Cancer Stem Cells ZIABC011003 $103,265 $30,979 Avital, Itzhak CCR (NCI)
25
ATBC Study ZIA CP010195-03031 $1,176,890 $47,076 Albanes, Demetrius DCEG (NCI)
26
Atlases to Report and Correlate Radiotherapy Dose Distributions with Outcomes 5R01CA129182-04 $435,472 $108,868 Jackson, Andrew SLOAN-KETTERING INSTITUTE FOR CANCER RES
27
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research ZIGBC010856 $14,609,987 $730,499 Custer, Mary CCR (NCI)
28
Baylor College of Medicine Cancer Center 3P30CA125123-06S1 $41,433 $2,072 OSBORNE, C BAYLOR COLLEGE OF MEDICINE
29
Baylor College of Medicine Cancer Center 3P30CA125123-06S2 $75,000 $3,750 OSBORNE, C BAYLOR COLLEGE OF MEDICINE
30
Baylor College of Medicine Cancer Center 5P30CA125123-06 $2,934,758 $146,738 OSBORNE, C BAYLOR COLLEGE OF MEDICINE
31
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins ZIABC010030 $806,557 $80,656 Ambudkar, Suresh CCR (NCI)
32
Biomarker Discovery for Hepatitis C Progression using Machine Learning Techniques 5K25CA127524-05 $133,197 $133,197 Spratt, Heidi UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
33
Biomarkers of Opisthorchis viverrini-induced cholangiocarcinoma 5R01CA155297-02 $521,314 $521,314 Brindley, Paul GEORGE WASHINGTON UNIVERSITY
34
Biosynthesis of Selenocysteine and Its Incorporation into Protein ZIABC010767 $160,128 $40,032 Hatfield, Dolph CCR (NCI)
35
Bone Marrow Stem Cells Participation in Solid Organ Cancers Carcinogenesis ZIABC011004 $154,897 $30,979 Avital, Itzhak CCR (NCI)
36
BRIT1, A NOVEL HEPATOCELLULAR CARCINOMA TUMOR SUPPRESSOR 5R21CA161513-02 $171,064 $171,064 LI, KAIYI BAYLOR COLLEGE OF MEDICINE
37
CALGB Member Site: University of California - San Francisco 3U10CA138561-03S1 $106,497 $2,130 Ryan, Charles UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
38
Cancer and Leukemia Group B 3U10CA031946-31S1 $114,228 $2,285 BERTAGNOLLI, MONICA BRIGHAM AND WOMEN'S HOSPITAL
39
Cancer and Leukemia Group B 5U10CA031946-31 $7,759,618 $155,192 BERTAGNOLLI, MONICA BRIGHAM AND WOMEN'S HOSPITAL
40
Cancer and Leukemia Group B 5U10CA032291-31 $495,751 $9,915 Burstein, Harold DANA-FARBER CANCER INSTITUTE
41
Cancer and Leukemia Group B 5U10CA047577-25 $99,190 $1,984 CRAWFORD, JEFFREY DUKE UNIVERSITY
42
Cancer and Leukemia Group B 3U10CA077597-14S1 $77,984 $1,560 Liu, Minetta GEORGETOWN UNIVERSITY
43
Cancer and Leukemia Group B 5U10CA077651-15 $212,393 $4,248 Hudis, Clifford SLOAN-KETTERING INSTITUTE FOR CANCER RES
44
Cancer and Leukemia Group B 5U10CA041287-27 $258,606 $5,172 KINDLER, HEDY UNIVERSITY OF CHICAGO
45
Cancer and Leukemia Group B 5U10CA047559-22 $134,116 $2,682 SHEA, THOMAS UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
46
Cancer and Leukemia Group B - Leukemia Correlative Sciences 5U10CA101140-10 $806,740 $16,135 MARCUCCI, GUIDO OHIO STATE UNIVERSITY
47
Cancer and Leukemia Group B - The Ohio State University 5U10CA077658-15 $487,632 $9,753 BLOOMFIELD, CLARA OHIO STATE UNIVERSITY
48
Cancer and Leukemia Group B CCOP Research Base 3U10CA037447-27S1 $405,901 $4,059 BERTAGNOLLI, MONICA BRIGHAM AND WOMEN'S HOSPITAL
49
Cancer and Leukemia Group B CCOP Research Base 5U10CA037447-28 $2,286,202 $22,862 BERTAGNOLLI, MONICA BRIGHAM AND WOMEN'S HOSPITAL
50
Cancer and Leukemia Group B Statistical Center 5U10CA033601-34 $4,701,770 $94,035 SARGENT, DANIEL MAYO CLINIC
Total relevant funding to Liver Cancer for this search: $64,559,887
Showing 1 - 50 of 431 results
Go to top